NexgenRx Inc (NXG) Key Financial Indicators

0.380
0.0000.00%

15min DelayMarket Closed Jan 14 16:00 ET

27.02MMarket Cap23.75P/E (TTM)

NXG Free Cash Flow (FCF)

Interested in knowing about NexgenRx Inc's free cash flow? The latest report shows it as 862.75K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: CAD

Quarterly

NXG Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of NexgenRx Inc shows that the company's current ratio is 1.11, indicating healthy liquidity.

Currency: CAD

Quarterly

NXG Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of NexgenRx Inc, the quick ratio is 0.11, indicating that the company can meet its short-term debt obligations.

Currency: CAD

Quarterly

NXG Return on Equity (ROE)

Want to learn more about the financial health of NexgenRx Inc? The latest ROE figure is 9.02%, indicating that the company has stable profitability.

Currency: CAD

Quarterly

NXG Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of NexgenRx Inc, the total asset return on investment (ROA) is 1.58%.

Currency: CAD

Quarterly

NXG Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check NexgenRx Inc's latest financial report to see how their gross margin is doing - currently at 83.41%.

Currency: CAD

Quarterly

NXG Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of NexgenRx Inc, the net profit margin is 12.78%, which is a good sign for its profitability.

Currency: CAD

Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"